STENTYS S.A. Company Profile

News Articles [ 27 Associated News Articles listed on BioPortfolio]

Self-expanding stent shows benefit in study-Stentys

* Stentys device has lower death rates than other products

STENTYS Clinical Study Demonstrating Superiority of Self-Apposing Stents Over Conventional Stents Published in American College of Cardiology Journal

APPOSITION II randomized study showed 28% malapposition in conventional stents versus 0% in STENTYS stents PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Jan 3, 2013 - STENTYS (FR0010949404 – ST...

STENTYS pitches flexible heart stent at conference

The STENTYS Bare Metal Stent, which is implanted in the artery without the need for a balloon catheter to eliminate blood clo -More- 

FDA grants IDE approval to initiate STENTYS Self-Apposing stent study

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to STENTYS to conduct a pivotal APPOSITION V clinical study for its Self-Apposing stent.

STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies

STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced...

RTI wins FDA nod for device used in soft tissue repair

The FDA has given RTI Biologics 510(k) clearance to market its porcine dermis implantable device, which is intended for use i -More- Stentys Pulls Back Curtain on APPOSITION III One-Year Res...

STENTYS Revenues for the First Half of 2012 Increase 92% over Prior Year

STENTYS (NYSE Euronext, FR0010949404 – STNT), a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (A...

STENTYS Clinical Study Demonstrating Superiority of Self-Apposing® Stents Over Conventional Stents Published in American College of Cardiology Journal

STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarctio...

Drugs and Medications [0 Results]

None

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Optical coherence tomography imaging of acute stent thrombosis after stentys stent implantation.

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

STENTYS S.A.

Based in Princeton, N.J., and Paris, STENTYS has developed a new generation of stents to treat acute myocardial infarction (AMI). Founded by Jacques Séguin, M.D., Ph.D., (also...

Stentys

Based in Princeton, N.J., and Paris, Stentys has developed a new generation of stents for the treatment of acute myocardial infarction. Founded by Jacques Séguin, M.D., Ph.D.,...